14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.16 $18.63 Friday, 3rd May 2024 ACAD stock ended at $17.05. This is 0.176% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.25% from a day low at $17.03 to a day high of $17.58.
90 days $16.16 $26.78
52 weeks $16.16 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Mar 30, 2023 $19.10 $19.10 $18.41 $18.70 1 495 375
Mar 29, 2023 $18.51 $18.99 $18.39 $18.98 1 127 137
Mar 28, 2023 $18.53 $18.71 $18.26 $18.43 772 353
Mar 27, 2023 $18.42 $18.72 $18.16 $18.60 1 018 229
Mar 24, 2023 $18.21 $18.31 $17.93 $18.24 1 408 499
Mar 23, 2023 $18.72 $18.85 $18.11 $18.32 1 155 399
Mar 22, 2023 $19.39 $19.39 $18.48 $18.50 1 461 686
Mar 21, 2023 $19.90 $20.03 $19.33 $19.45 1 367 431
Mar 20, 2023 $19.99 $20.25 $19.76 $19.76 1 361 158
Mar 17, 2023 $20.43 $20.43 $19.72 $19.80 4 753 219
Mar 16, 2023 $19.80 $20.83 $19.47 $20.62 1 774 944
Mar 15, 2023 $20.09 $20.21 $19.40 $19.85 2 101 875
Mar 14, 2023 $20.07 $20.78 $19.75 $20.38 3 425 721
Mar 13, 2023 $20.07 $20.15 $18.73 $19.41 6 508 010
Mar 10, 2023 $20.81 $20.81 $19.97 $20.37 2 376 949
Mar 09, 2023 $20.86 $21.02 $20.21 $20.51 1 557 854
Mar 08, 2023 $20.46 $20.82 $20.12 $20.77 1 426 240
Mar 07, 2023 $20.69 $20.82 $20.32 $20.36 1 416 642
Mar 06, 2023 $20.42 $20.69 $19.96 $20.63 1 734 437
Mar 03, 2023 $20.51 $20.54 $19.97 $20.34 1 940 261
Mar 02, 2023 $20.82 $20.91 $20.05 $20.29 1 695 015
Mar 01, 2023 $20.79 $21.29 $20.50 $20.92 2 021 316
Feb 28, 2023 $19.85 $21.87 $19.35 $20.69 3 622 594
Feb 27, 2023 $19.14 $19.45 $19.03 $19.40 1 529 479
Feb 24, 2023 $18.78 $19.02 $18.77 $18.92 938 281
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT